Editorial: Drug targets in cancer chemotherapy.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D003609:Dactinomycin / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004791:Enzyme Inhibitors; D005472:Fluorouracil / Q000627:therapeutic use; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D008727:Methotrexate / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*; D012293:Rifampin / Q000627:therapeutic use
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D007527:Isoenzymes; D003609:Dactinomycin; D004317:Doxorubicin; D005472:Fluorouracil; D012293:Rifampin; D008727:Methotrexate